Drugs News and Research

RSS

No scientific proof that patients with Alzheimer's disease benefit from drugs containing the agent memantine

There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. This is the conclusion in the final report that the Institute for Quality and Efficiency in Health Care (IQWiG) published in September 2009.

29 Oct 2009

TNF therapy does not raise cancer risk in RA patients; overall cancer risk comparable to those not taking immunosuppressive drugs

A recent study by Swedish researchers found that rheumatoid arthritis (RA) patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor (TNF) therapy.

29 Oct 2009

New anti-cancer medications may help in managing cancerous conditions

Bold new strategies in the battle against cancer may turn forms of the disease that presently are incurable into manageable conditions that can be controlled for long periods of time, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

29 Oct 2009

Moores UCSD Cancer Center awarded $20 million for cancer research

Researchers led by Moores UCSD Cancer Center Director Dennis A. Carson, MD, professor of medicine, and Catriona Jamieson, MD, PhD, assistant professor of medicine and director of the Cancer Stem Cell Research Program at the Moores UCSD Cancer Center have been awarded $20 million over four years to develop novel drugs against leukemia stem cells.

28 Oct 2009

NIGMS accelerates induced pluripotent stem cells study with Recovery Act funds

The National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health, is using $5.4 million of Recovery Act funds to accelerate basic studies of induced pluripotent stem cells. These cells, abbreviated iPS, are reprogrammed from skin or other easily obtained adult cells and appear to be similar to stem cells derived from embryos.

28 Oct 2009

iMDsoft and Codonics launch an anesthesia solution with a syringe labeling system

iMDsoft®, a global leader in clinical information systems for perioperative, critical, and acute care, and Codonics of Middleburg Heights, OH, a leading provider of image distribution solutions for the medical industry, have announced an agreement that will complement iMDsoft’s anesthesia solution with an innovative syringe labeling system. The system will be fully integrated with the MetaVision® Anesthesia Information Management System (AIMS).

28 Oct 2009

NIH awards DiscoveryBioMed grant to develop therapies for cystic fibrosis

DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH). The $308,000 grant will be used to advance certain small molecule drug discovery programs designed to correct the genetic mutation most common to cystic fibrosis (CF).

28 Oct 2009

Nevada case raises question of pharmacies' liability in drug abuse accidents

A Nevada case causes concern for pharmacies about possible liability for actions taken by customers who may abuse drugs. The Wall Street Journal reports on the case of Patricia Copening, who pleaded guilty to reckless driving after her car swerved off a highway and struck and killed a 21-year-old and injured a 33-year-old.

28 Oct 2009

Newspaper investigates dangerous mix of nursing homes and psychotropic drugs

Illinois nursing home patients often receive psychotropic drugs without cause, which poses various health dangers and even death, the Chicago Tribune reports as part of its Compromised Care series.

28 Oct 2009

Quinnova Pharmaceuticals raises $17.4 million through Series B financing

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.

28 Oct 2009

FDA approves the 100th antiretroviral drug in association with PEPFAR

The U.S. Department of Health and Human Services (HHS) today marked the recent approval of the 100th antiretroviral drug in association with the President's Emergency Plan for AIDS Relief (PEPFAR), aimed at the prevention, treatment, and care of people infected with and affected by HIV/AIDS worldwide.

28 Oct 2009

73% increase in antiviral prescriptions in the past two weeks: SDI

According to SDI’s Vector One®: National, antiviral prescriptions rose dramatically last week to over 648,000, an increase of more than 73% in the past two weeks. Antiviral prescriptions have climbed each week since the week ending Aug. 21, but the increases in the past two weeks have been significant.

28 Oct 2009

Wellpoint announces third quarter 2009 financial results; net income is 1.53 per share

WellPoint, Inc. (NYSE: WLP) today announced that third quarter 2009 net income was $730.2 million, or $1.53 per share, including net investment gains of $21.5 million pre-tax, or $0.03 per share, and an impairment charge totaling $205.5 million pre-tax, or $0.28 per share, for certain intangible assets.

28 Oct 2009

Scientists test rapamycin's effectiveness at rescuing impaired nerve cells

Johns Hopkins scientists report having used a commercially available drug to successfully "rescue" animal brain cells that they had intentionally damaged by manipulating a newly discovered gene that links susceptibility genes for schizophrenia and autism.

28 Oct 2009

Deloitte releases "Acquisitions versus Product Development: An Emerging Trend in Life Sciences" report

Recent pharmaceutical mergers and acquisitions indicate a trend of consolidation in the industry. Companies are looking for ways to bolster their research and development pipelines and reduce costs by rationalizing their combined sales and reducing other corporate overhead.

28 Oct 2009

Study of ‘real-life’ experiences of patients undergoing 5-ASA treatment for ulcerative colitis

InfoMedics, Inc., a company that engages patients and physicians to communicate better through the delivery of treatment feedback, has poster presentations at three industry conferences in October 2009. All of these studies provide a unique look at real-life patient feedback regarding experiences with medications for chronic conditions including ulcerative colitis (UC) and attention-deficit/hyperactivity disorder (ADHD) in adults and children.

28 Oct 2009

Catheter-directed therapy safe and effective for treating acute pulmonary embolism

William Kuo, MD, was the on-call interventional radiologist one Friday night three years ago when he received a call from the intensive care unit at Stanford Hospital & Clinics. He was asked to attend to a 62-year-old woman who had collapsed at home and was rushed to the emergency room with massive blood clots in her lungs.

28 Oct 2009

PPD to evaluate FDA's post-market spontaneous adverse event surveillance system

PPD, Inc. today announced it has been awarded a contract by the U.S. Food and Drug Administration (FDA) to evaluate the agency’s Center for Drug Evaluation and Research (CDER) post-market spontaneous adverse event surveillance system. The company will conduct a thorough evaluation of the value of the spontaneous adverse event reports to support safety-related regulatory actions and report its findings to the FDA and the public.

28 Oct 2009

Susceptibility to schizophrenia and autism may have common genetic fingerprints, says researchers

28 Oct 2009

U.S. PTO awards Endocyte patent for vitamin receptor binding anti-cancer agents

Officials at Endocyte Inc., a cancer drug discovery and development company, announced Tuesday (Oct. 27, 2009) that the company has been awarded a patent from the U.S. Patent and Trademark Office covering vitamin receptor binding anti-cancer agents.

28 Oct 2009

Drugs News and Research

No scientific proof that patients with Alzheimer's disease benefit from drugs containing the agent memantine

TNF therapy does not raise cancer risk in RA patients; overall cancer risk comparable to those not taking immunosuppressive drugs

New anti-cancer medications may help in managing cancerous conditions

Moores UCSD Cancer Center awarded $20 million for cancer research

NIGMS accelerates induced pluripotent stem cells study with Recovery Act funds

iMDsoft and Codonics launch an anesthesia solution with a syringe labeling system

NIH awards DiscoveryBioMed grant to develop therapies for cystic fibrosis

Nevada case raises question of pharmacies' liability in drug abuse accidents

Newspaper investigates dangerous mix of nursing homes and psychotropic drugs

Quinnova Pharmaceuticals raises $17.4 million through Series B financing

FDA approves the 100th antiretroviral drug in association with PEPFAR

73% increase in antiviral prescriptions in the past two weeks: SDI

Wellpoint announces third quarter 2009 financial results; net income is 1.53 per share

Scientists test rapamycin's effectiveness at rescuing impaired nerve cells

Deloitte releases "Acquisitions versus Product Development: An Emerging Trend in Life Sciences" report

Study of ‘real-life’ experiences of patients undergoing 5-ASA treatment for ulcerative colitis

Catheter-directed therapy safe and effective for treating acute pulmonary embolism

PPD to evaluate FDA's post-market spontaneous adverse event surveillance system

Susceptibility to schizophrenia and autism may have common genetic fingerprints, says researchers

U.S. PTO awards Endocyte patent for vitamin receptor binding anti-cancer agents

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News